Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-14

Clinical Trial Update: Olanzapine in the Treatment of Anorexia Nervosa [Phase 4]

View source ↗

Summary

This document notes the completion of a Phase 4 trial evaluating olanzapine for anorexia nervosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zyprexa (olanzapine)

Snippet

Sponsor: Northwell Health | Conditions: Anorexia Nervosa | Phase 4 | Status: COMPLETED